A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer

Journal of Virological Methods

Volumn 128, Issue 1-2, 2005, Pages 93-103

  Hu, Kimberly ^a,b   Clément, Jean Francois ^a,b   Abrahamyan, Levon ^a,b   Strebel, Klaus ^c   Bouvier, Michel ^d   Kleiman, Lawrence ^b,e   Mouland, Andrew J ^a,b,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

BRET2; HIV 1; Inhibitor; Protease; Vif

Indexed keywords

AMPRENAVIR; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; LUCIFERASE; PROTEINASE; RNA BINDING PROTEIN; SAQUINAVIR;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BIOSENSOR; CODON; CONCENTRATION RESPONSE; ENERGY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR SPACE; MAMMAL CELL; MEASUREMENT; MEDICAL TECHNOLOGY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA BINDING; SCREENING; SENSITIVITY ANALYSIS; VALIDATION PROCESS; WESTERN BLOTTING;

BIOSENSING TECHNIQUES; CELL LINE; ENERGY TRANSFER; GENE PRODUCTS, VIF; GREEN FLUORESCENT PROTEINS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LUCIFERASES, RENILLA; LUMINESCENT MEASUREMENTS; MICROBIAL SENSITIVITY TESTS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; RENILLA MULLERI; RENILLA RENIFORMIS;

EID: 22144495695     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.04.012     Document Type: Article

References (48)

1. The Pharmaceutical Research and Manufacturers of America (PhRMA), http://www.phrma.org/newmedicines/aids/.
2. H. Akari, M. Fujita, S. Kao, M.A. Khan, M. Shehu-Xhilaga, A. Adachi, and K. Strebel High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site J. Biol. Chem. 279 2004 12355 12362
3. S. Angers, A. Salahpour, E. Joly, S. Hilairet, D. Chelsky, M. Dennis, and M. Bouvier Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) Proc. Natl. Acad. Sci. U.S.A. 97 2000 3684 3689
4. G.J. Babcock, M. Farzan, and J. Sodroski Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor J. Biol. Chem. 278 2003 3378 3385
5. P. Bagossi, J. Kadas, G. Miklossy, P. Boross, I.T. Weber, and J. Tozser Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases J. Virol. Methods 119 2004 87 93
6. L. Baraz, M. Hutoran, I. Blumenzweig, M. Katzenellenbogen, A. Friedler, C. Gilon, M. Steinitz, and M. Kotler Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region J. Gen. Virol. 83 2002 2225 2230
7. M. Bardy, B. Gay, S. Pebernard, N. Chazal, M. Courcoul, R. Vigne, E. Decroly, and P. Boulanger Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing J. Gen. Virol. 82 2001 2719 2733
8. A. Baruch, D.A. Jeffery, and M. Bogyo Enzyme activity - it's all about image Trends Cell Biol. 14 2004 29 35
9. V. Beriault, J.F. Clement, K. Levesque, C. Lebel, X. Yong, B. Chabot, E.A. Cohen, A.W. Cochrane, W.F. Rigby, and A.J. Mouland A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag, and Vpr localization J. Biol. Chem. 279 2004 44141 44153
10. L. Bertrand, S. Parent, M. Caron, M. Legault, E. Joly, S. Angers, M. Bouvier, M. Brown, B. Houle, and L. Menard The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS) J. Recept. Signal Transduct. Res. 22 2002 533 541
11. J.E. Blanchard, N.H. Elowe, C. Huitema, P.D. Fortin, J.D. Cechetto, L.D. Eltis, and E.D. Brown High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase Chem. Biol. 11 2004 1445 1453
12. N. Boute, K. Pernet, and T. Issad Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer Mol. Pharmacol. 60 2001 640 645
13. M. Bouyac, M. Courcoul, G. Bertoia, Y. Baudat, D. Gabuzda, D. Blanc, N. Chazal, P. Boulanger, J. Sire, R. Vigne, and B. Spire Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor J. Virol. 71 1997 9358 9365
14. L. Chatel-Chaix, J.F. Clement, C. Martel, V. Beriault, A. Gatignol, L. DesGroseillers, and A.J. Mouland Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles Mol. Cell Biol. 24 2004 2637 2648
15. E. De Clercq Antiviral drugs in current clinical use J. Clin. Virol. 30 2004 115 133
16. A. Feher, I.T. Weber, P. Bagossi, P. Boross, B. Mahalingam, J.M. Louis, T.D. Copeland, I.Y. Torshin, R.W. Harrison, and J. Tozser Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites Eur. J. Biochem. 269 2002 4114 4120
17. D. Germain-Desprez, M. Bazinet, M. Bouvier, and M. Aubry Oligomerization of transcriptional intermediary factor 1 regulators and interaction with ZNF74 nuclear matrix protein revealed by bioluminescence resonance energy transfer in living cells J. Biol. Chem. 278 2003 22367 22373
18. Guo, F., Gabor, J., Cen, S., Hu, K., Mouland, A.J., Kleiman, L., 2005. Stabilization of HIV-1 GagPol by Lysyl-tRNA Synthetase. J. Biol. Chem., in press.
19. Y. Huang, W.P. Kong, and G.J. Nabel Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression J. Virol. 75 2001 4947 4951
20. Y. Huang, J. Wang, A. Shalom, Z. Li, A. Khorchid, M.A. Wainberg, and L. Kleiman Primer tRNA3Lys on the viral genome exists in unextended and two-base extended forms within mature human immunodeficiency virus type 1 J. Virol. 71 1997 726 728
21. H. Issafras, S. Angers, S. Bulenger, C. Blanpain, M. Parmentier, C. Labbe-Jullie, M. Bouvier, and S. Marullo Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors J. Biol. Chem. 277 2002 34666 34673
22. H. Javanbakht, R. Halwani, S. Cen, J. Saadatmand, K. Musier-Forsyth, H. Gottlinger, and L. Kleiman The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly J. Biol. Chem. 278 2003 27644 27651
23. S. Kao, H. Akari, M.A. Khan, M. Dettenhofer, X.F. Yu, and K. Strebel Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection J. Virol. 77 2003 1131 1140
24. L. Kleiman, and S. Cen The tRNALys packaging complex in HIV-1 Int. J. Biochem. Cell Biol. 36 2004 1776 1786
25. J.C. Lee, C.F. Chang, Y.H. Chi, D.R. Hwang, and J.T. Hsu A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells J. Virol. Methods 116 2004 27 33
26. K. Lindsten, T. Uhlikova, J. Konvalinka, M.G. Masucci, and N.P. Dantuma Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity Antimicrob. Agents Chemother. 45 2001 2616 2622
27. E.D. Matayoshi, G.T. Wang, G.A. Krafft, and J. Erickson Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer Science 247 1990 954 958
28. T.J. McQuade, A.G. Tomasselli, L. Liu, V. Karacostas, B. Moss, T.K. Sawyer, R.L. Heinrikson, and W.G. Tarpley A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation Science 247 1990 454 456
29. J.F. Mercier, A. Salahpour, S. Angers, A. Breit, and M. Bouvier Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer J. Biol. Chem. 277 2002 44925 44931
30. A.J. Mouland, M. Coady, X.J. Yao, and E.A. Cohen Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression Virology 292 2002 321 330
31. A.J. Mouland, J. Mercier, M. Luo, L. Bernier, L. DesGroseillers, and E.A. Cohen The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation J. Virol. 74 2000 5441 5451
32. K.L. Nguyen, M. llano, H. Akari, E. Miyagi, E.M. Poeschla, K. Strebel, and S. Bour Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression Virology 319 2004 163 175
33. A. Ohagen, and D. Gabuzda Role of Vif in stability of the human immunodeficiency virus type 1 core J. Virol. 74 2000 11055 11066
34. Y. Percherancier, Y. Berchiche, I. Slight, R. Volkmer-Engert, H. Tamamura, N. Fujii, M. Bouvier, and N. Heveker Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers J. Biol. Chem. 2005
35. J. Perroy, S. Pontier, P.G. Charest, M. Aubry, and M. Bouvier Real-time monitoring of ubiquitination in living cells by BRET Nat. Methods 1 2004 203 208
36. S.C. Pettit, N. Sheng, R. Tritch, S. Erickson-Viitanen, and R. Swanstrom The regulation of sequential processing of HIV-1 Gag by the viral protease Adv. Exp. Med. Biol. 436 1998 15 25
37. A. Roda, M. Guardigli, P. Pasini, and M. Mirasoli Bioluminescence and chemiluminescence in drug screening Anal. Bioanal. Chem. 377 2003 826 833
38. M. Shehu-Xhilaga, H.G. Kraeusslich, S. Pettit, R. Swanstrom, J.Y. Lee, J.A. Marshall, S.M. Crowe, and J. Mak Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation J. Virol. 75 2001 9156 9164
39. N. Sheng, and S. Erickson-Viitanen Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent J. Virol. 68 1994 6207 6214
40. N. Sheng, S.C. Pettit, R.J. Tritch, D.H. Ozturk, M.M. Rayner, R. Swanstrom, and S. Erickson-Viitanen Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease J. Virol. 71 1997 5723 5732
41. R.L. Shoeman, B. Honer, T.J. Stoller, C. Kesselmeier, M.C. Miedel, P. Traub, and M.C. Graves Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein Proc. Natl. Acad. Sci. U.S.A. 87 1990 6336 6340
42. P.R. Strack, M.W. Frey, C.J. Rizzo, B. Cordova, H.J. George, R. Meade, S.P. Ho, J. Corman, R. Tritch, and B.D. Korant Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2 Proc. Natl. Acad. Sci. U.S.A. 93 1996 9571 9576
43. M. Wallin, J. Deinum, L. Goobar, and U.H. Danielson Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases J. Gen. Virol. 71 1990 1985 1991
44. Y. Xu, D.W. Piston, and C.H. Johnson A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins Proc. Natl. Acad. Sci. U.S.A. 96 1999 151 156
45. X.J. Yao, A.J. Mouland, R.A. Subbramanian, J. Forget, N. Rougeau, D. Bergeron, and E.A. Cohen Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells J. Virol. 72 1998 4686 4693
46. H. Zhang, R.J. Pomerantz, G. Dornadula, and Y. Sun Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process J. Virol. 74 2000 8252 8261
47. Y. Zhang, and E. Barklis Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation J. Virol. 71 1997 6765 6776
48. J. Zhou, X. Yuan, D. Dismuke, B.M. Forshey, C. Lundquist, K.H. Lee, C. Aiken, and C.H. Chen Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation J. Virol. 78 2004 922 929